Research
Energy balance
The approval of semaglutide by the FDA was based on the results of clinical trials.
Practitioners can inform patients that semaglutide is FDA-approved for weight management based on clinical evidence.
StrongSupportsmedium confidence
The approval came after the publication of the Semaglutide Treatment Effect in People with Obesity clinical trials.
Why this rating
Based on the mention of FDA approval linked to clinical trials.
Source
Semaglutide for Weight Loss: Was It Worth the Weight?
Joel Novograd et al. · Cardiology in Review · 2022
DOI 10.1097/crd.0000000000000430
reviewCited 14×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →